scispace - formally typeset
Journal ArticleDOI

Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology

Reads0
Chats0
TLDR
The PPI network, GO enrichment analysis and KEGG pathway enrichment analysis suggested that ZSD can exerte anti-inflammatory and analgesic effects on the treatment of GA by reducing decreasing inflammatory reaction, alleviating ROS accumulation, and attenuating pain.
About
This article is published in Computational Biology and Chemistry.The article was published on 2021-02-01. It has received 30 citations till now. The article focuses on the topics: KEGG & GeneCards.

read more

Citations
More filters
Journal ArticleDOI

Elaborate the Mechanism of Ancient Classic Prescriptions (Erzhi Formula) in Reversing GIOP by Network Pharmacology Coupled with Zebrafish Verification

TL;DR: Erzhi formula (EZF) can promote bone formation and reversed GIOP through “multicomponent/multitarget/multipathway” and the medium dose of EZF may be the most suitable concentration for the treatment of GIOP in zebrafish model.
Journal ArticleDOI

Efficacy and Safety of Qinpi Tongfeng Formula Combined with Bloodletting Therapy in the Treatment of Acute Gouty Arthritis: A Study Protocol for a Randomized Controlled Trial

TL;DR: The results of this study will provide reliable clinical evidence for the clinical use of QPTFF combined with bloodletting in the treatment of AGA.
Journal ArticleDOI

Myrtenal and β-caryophyllene oxide screened from Liquidambaris Fructus suppress NLRP3 inflammasome components in rheumatoid arthritis.

TL;DR: In this paper, the active ingredients of liquidambaris fructus (LF) were investigated using network pharmacology and molecular docking methods, and their inhibition of NLRP3 inflammasome activation was verified in the human rheumatoid arthritis fibroblast-like synovial cells (RA-FLS) model.
Journal ArticleDOI

Integrated Chemical Molecular Docking with Network Pharmacology to Study the Molecular Mechanism of JianPi YiQi BuSui Method for Treating Myasthenia Gravis

TL;DR: The pharmacodynamic basis and action mechanism of JPYQBSM in the treatment of myasthenia gravis were predicted by computer network pharmacological technology and molecular docking technology of chemical composition.
Journal ArticleDOI

Integrated chemical molecular docking with network pharmacology to study the molecular mechanism of JianPi YiQi BuSui method for treating myasthenia gravis

TL;DR: Wang et al. as discussed by the authors provided new insights into specific mechanisms underlying JPYQBSM therapeutic effects for alleviating myasthenia gravis (MG), a chronic autoimmune neuromuscular disorder, which remains challenging due to side effects associated with modern medications which was used to treat the disease.
References
More filters
Journal ArticleDOI

The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible.

TL;DR: In the latest version 10.5 of STRING, the biggest changes are concerned with data dissemination: the web frontend has been completely redesigned to reduce dependency on outdated browser technologies, and the database can now also be queried from inside the popular Cytoscape software framework.
Journal ArticleDOI

Gout-associated uric acid crystals activate the NALP3 inflammasome

TL;DR: It is shown that MSU and CPPD engage the caspase-1-activating NALP3 (also called cryopyrin) inflammasome, resulting in the production of active interleukin (IL)-1β and IL-18 in mice deficient in the IL-1β receptor.
Journal ArticleDOI

TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.

TL;DR: The particular strengths of TCMSP are the composition of the large number of herbal entries, and the ability to identify drug-target networks and drug-disease networks, which will help revealing the mechanisms of action of Chinese herbs, uncovering the nature ofTCM theory and developing new herb-oriented drugs.
Journal ArticleDOI

The NLRP3 Inflammasome: A Sensor for Metabolic Danger?

TL;DR: It is proposed that the NLRP3 inflammasome contributes to the pathogenesis of T2DM and gout by functioning as a sensor for metabolic stress.
Journal ArticleDOI

NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux

TL;DR: In this paper, the authors identify NEK7, a member of the family of mammalian NIMA-related kinases (NEK proteins), as an NLRP3-binding protein that acts downstream of potassium efflux to regulate IL-1β and IL-18 proteins.
Related Papers (5)